Shell Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Shell Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$40K	Sell	1,492 -2,681	-64%	-$69.2K	﹤0.01%	925
2025 Q2	$96K	Sell	4,173 -460	-10%	-$11.4K	﹤0.01%	1019
2025 Q1	$134K	Sell	4,633 -201	-4%	-$6.42K	0.01%	932
2024 Q4	$179K	Sell	4,834 -16	-0.3%	-$732	0.01%	876
2024 Q3	$235K	Buy	+4,850	New	+$213K	0.01%	771
2024 Q1	$205K	Sell	5,128 -514	-9%	-$26.5K	0.01%	809
2023 Q4	$349K	Sell	5,642 -1,697	-23%	-$89.1K	0.02%	650
2023 Q3	$338K	Sell	7,339 -3,696	-33%	-$202K	0.01%	716
2023 Q2	$634K	Sell	11,035 -63	-0.6%	-$2.79K	0.03%	498
2023 Q1	$416K	Sell	11,098 -39	-0.4%	-$1.28K	0.02%	640
2022 Q4	$312K	Sell	11,137 -2,261	-17%	-$65.7K	0.01%	756
2022 Q3	$376K	Sell	13,398 -3,510	-21%	-$115K	0.01%	717
2022 Q2	$588K	Sell	16,908 -15,495	-48%	-$553K	0.02%	627
2022 Q1	$1.16M	Sell	32,403 -4,796	-13%	-$136K	0.03%	451
2021 Q4	$866K	Buy	37,199 +177	+0.5%	+$3.62K	0.02%	626
2021 Q3	$704K	Sell	37,022 -1,600	-4%	-$31.3K	0.02%	687
2021 Q2	$779K	Buy	38,622 +2,090	+6%	+$39.4K	0.02%	689
2021 Q1	$669K	Buy	36,532 +18,908	+107%	+$352K	0.01%	724
2020 Q4	$354K	Hold	17,624	–	–	0.01%	941
2020 Q3	$330K	Buy	17,624 +3,437	+24%	+$69.2K	0.01%	865
2020 Q2	$319K	Buy	+14,187	New	+$260K	0.01%	864

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Shell Asset Management's AMPH Position: Q3 2025 in Review

Shell Asset Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 64% in Q3 2025, selling an estimated $69.2K and leaving 1,492 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Shell Asset Management first reported a position in AMPH in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.16M in Q1 2022. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

Shell Asset Management held 1,492 shares of Amphastar Pharmaceuticals worth $40K as of Q3 2025.
Shell Asset Management sold 2,681 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $69.2K.
Amphastar Pharmaceuticals made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #925 holding.
Shell Asset Management first reported a position in Amphastar Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
Shell Asset Management's Amphastar Pharmaceuticals position peaked at $1.16M in Q1 2022.
243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.